Stonepine Capital Management, LLC 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 10:28 am Sale |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Stonepine Capital Management, LLC | 0 0.000% |
-4,006,185 (Position Closed) |
Filing |
| 2022-02-11 5:47 pm Purchase |
2021-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Stonepine Capital Management, LLC | 4,006,185 5.900% |
506,185 (+14.46%) |
Filing |
| 2021-04-29 4:48 pm Purchase |
2021-04-20 | 13G | Ovid Therapeutics Inc. OVID |
Stonepine Capital Management, LLC | 3,500,000 5.300% |
3,500,000 (New Position) |
Filing |